Medtronic Snags FDA Approval for DBS Therapy for People with Advanced Parkinson’s

The FDA granted an approval to Medtronic for its deep brain stimulation therapy for people with Parkinson’s with recent onset of motor complications.

“This decision by the FDA is significant in that Medtronic DBS Therapy may be considered before the symptoms and complications of disease becomes severe,” according to Mahlon DeLong, the W.P. Timmie professor of neurology at Emory University School of Medicine, in a statement.

As a result of the FDA’s action, Medtronic DBS therapy may be used on patients who have had Parkinson’s for at least four years, along with recent onset of motor complications, or motor complications of longer-standing duration that are not adequately controlled with medication. — Anisa Jibrell